Sensi.AI – World’s First Virtual Care Assistant
Miki Rossanis, Head of Clinical Development at Sensi.AI, based in Tel Aviv, discusses the world's first AI-powered in-home virtual care agent.
5347 articles
Miki Rossanis, Head of Clinical Development at Sensi.AI, based in Tel Aviv, discusses the world's first AI-powered in-home virtual care agent.
Returning guest, Lloyd Miller, MD, PhD, Vice President, Immunodermatology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & ...
Angela Mickalide, PhD, MCHES, Vice President, Programs & Education, American College of Preventive Medicine discusses her involvement in the Vaccine Con...
Dennis Urbaniak, Executive Vice President of Digital Therapeutics at Orexo, a pharmaceutical and digital therapeutics company that addresses the unmet n...
Irwin Stromeyer, Owner, Sterile Space Infection Defence, LLC, discusses biopreparedness, the current 'twin-demic’ of COVID and FLU or 'Flurona', and s...
Amy Peterson, MD, President and Chief Operating Officer at CytomX Therapeutics, Inc. Learn more on Health Professional Radio.
Vivek Shah, MD, Director of Outpatient Arthroplasty in the Department of Orthopedics and a member of the faculty at Harvard Medical Schoo...
Jennifer Lewey, M.D., MPH, and Go Red for Women volunteer talks about how nearly 45% of women in their twenties and up are living with some form of ca...
Prash Puspanathan, co-founders of Enosis Therapeutics, an Australia-based medical technology and psychedelic research company, formed to advance experie...
Jeff Stark, Head of US Medical Immunology at UCB, discusses new long-term complete skin clearance data for bimekizumab in the treatment of moderate to s...